Sberbank, founded the company “Immunotechnology”, the main activities which will be the wholesale trade of pharmaceutical products, pharmaceutical substances, medicinal preparations and scientific research and development in biotechnology. The company was registered on 15 may, 100% of it belongs to the savings Bank, with registered capital of 50 million rubles, write “Vedomosti”.
The General Director of the company has appointed Dmitry Efimov, the former General Director “Nizhfarm” and senior Vice President of Stada CIS. Now he, according to SPARK, a member of the Board of Directors Medicalinstrument plant. V. I. Lenin Nizhny Novgorod and Nizhny Novgorod pharmacy network.
Sberbank also offered its employees to volunteer in the testing of vaccines against coronavirus. About it reported mass media with reference to the copy of the letter was provided to employees of the Bank. It lists the requirements for volunteers and contraindications to participation in the program.